KFDA to accept industry's revisions on specification and testing methods

Published: 2003-09-16 06:59:00

Updated: 2003-09-16 06:59:00

The Korea Food and Drug Administration said in a recently held special KGMP surveillance reporting session that it would welcome any revisions on specification and testing methods as part of its efforts to improve the quality of drugs.

Such KFDA's position came as the current specification and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK